High-risk Prognostic Tumor Features of Squamous Cell Carcinomas in Organ Transplant Recipients Compared With the General Population.


Journal

JAMA dermatology
ISSN: 2168-6084
Titre abrégé: JAMA Dermatol
Pays: United States
ID NLM: 101589530

Informations de publication

Date de publication:
01 08 2023
Historique:
pmc-release: 14 06 2024
medline: 17 8 2023
pubmed: 14 6 2023
entrez: 14 6 2023
Statut: ppublish

Résumé

The extent to which major high-risk features of squamous cell carcinomas (SCCs) in organ transplant recipients (OTRs) differ from SCCs in the general population is not known. To quantify the relative frequency of perineural invasion, invasion below the dermis, lack of cellular differentiation, and tumor diameter greater than 20 mm in SCCs in OTRs and the general population, by anatomic site. This dual-cohort study in Queensland, Australia, included a cohort of OTRs at high risk of skin cancer ascertained from 2012 to 2015 (Skin Tumours in Allograft Recipients [STAR] study) and a population-based cohort ascertained from 2011 (QSkin Sun and Health Study). The STAR study comprised population-based lung transplant recipients and kidney and liver transplant recipients at high risk of skin cancer recruited from tertiary centers and diagnosed with histopathologically confirmed SCC from 2012 to 2015. The QSkin participants were recruited from Queensland's general adult population, and primary SCCs diagnosed from 2012 to 2015 were ascertained through Medicare (national health insurance scheme) and linked with histopathology records. Data analysis was performed from July 2022 to April 2023. Prevalence ratio (PR) of head/neck location, perineural invasion, tumor invasion to/beyond subcutaneous fat, poor cellular differentiation, and tumor diameter greater than 20 mm among SCCs in OTRs vs the general population. There were 741 SCCs excised from 191 OTRs (median [IQR] age, 62.7 [56.7-67.1] years; 149 [78.0%] male) and 2558 SCCs from 1507 persons in the general population (median [IQR] age, 63.7 [58.0-68.8] years; 955 [63.4%] male). The SCCs developed most frequently on the head/neck in OTRs (285, 38.6%), but on arms/hands in the general population (896, 35.2%) (P < .001). After adjusting for age and sex, perineural invasion was more than twice as common in OTRs as in population cases (PR, 2.37; 95% CI, 1.70-3.30), as was invasion to/beyond subcutaneous fat (PR, 2.37; 95% CI, 1.78-3.14). Poorly vs well-differentiated SCCs were more than 3-fold more common in OTRs (PR, 3.45; 95% CI, 2.53-4.71), and prevalence of tumors greater than 20 mm vs 20 mm or smaller was moderately higher in OTRs (PR, 1.52; 95% CI, 1.08-2.12). In this dual-cohort study, SCCs in OTRs had significantly worse prognostic features than SCCs in the general population, reinforcing the necessity of early diagnosis and definitive management of SCCs in OTRs.

Identifiants

pubmed: 37314794
pii: 2805792
doi: 10.1001/jamadermatol.2023.1574
pmc: PMC10267841
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

854-858

Auteurs

Nirmala Pandeya (N)

Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Nicole Isbel (N)

Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Scott Campbell (S)

Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Daniel C Chambers (DC)

Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Queensland, Australia.
School of Clinical Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Peter Hopkins (P)

Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Queensland, Australia.
School of Clinical Medicine, The University of Queensland, Brisbane, Queensland, Australia.

H Peter Soyer (HP)

Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.
Department of Dermatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Zainab Jiyad (Z)

Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Department of Dermatology, St George's Hospital, London, United Kingdom.

Elsemieke I Plasmeijer (EI)

Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
The Netherlands Cancer Institute, Amsterdam, the Netherlands.

David C Whiteman (DC)

Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Catherine M Olsen (CM)

Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Adele C Green (AC)

Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
CRUK Manchester Institute and Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH